(Q34030127)

30 July 2017

1 reference

title

Esomeprazole. (English)

1 reference

30 July 2017

1 reference

ChEBI release 2020-05-28

Spencer CM

1

1 reference

30 July 2017

Faulds D

series ordinal

2

1 reference

30 July 2017

publication date

1 August 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

60

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

321-9; discussion 330-1

1 reference

Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial

30 July 2017

cites work

1 reference

12 December 2020

Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs

1 reference

12 December 2020

Appropriate acid suppression for the management of gastro-oesophageal reflux disease

1 reference

12 December 2020

Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects

1 reference

12 December 2020

Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease

1 reference

12 December 2020

Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group

1 reference

12 December 2020

Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology

1 reference

12 December 2020

10.2165/00003495-200060020-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1023439957

0 references

1 reference